tenk.fyi

X4 Pharmaceuticals, Inc

XFORNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$2.6M

Net Income

-$37.5M

63.0% YoY

EPS

$-0.19

66.7% YoY

Cash

$55.7M

43.9% YoY

FY 2024 · As of 2024-12-31